Moderate coffee consumption linked to lower risk of multiple cardiometabolic diseases

Hori­zon Ther­a­peu­tics dis­closed Fri­day af­ter­noon that its an­ti­body drug daxdil­imab failed a mid-stage study for lu­pus. In the 214-pa­tient Phase II tri­al, there was no

Neu­rol­o­gists who were asked about new treat­ments for amy­otroph­ic lat­er­al scle­ro­sis (ALS) say they val­ue ef­fi­ca­cy and qual­i­ty-of-life im­prove­ments over safe­ty for drugs in de­vel­op­ment.

Almost 40% of patients with relapsed/refractory lymphomas achieved complete responses (CRs) with a five-drug regimen that targeted different cancer-survival pathways, a preliminary clinical trial showed.